Cellectis (CLLS) Deferred Taxes (2023 - 2026)
Cellectis (CLLS) posted quarterly Deferred Taxes of -$1.7 million for Q1 2026, up 49.6% year-over-year from -$1.1 million in Q1 2025, and up 91.04% quarter-over-quarter from -$18.9 million in Q3 2025.
Cellectis (CLLS) Deferred Taxes (2023 - 2026) Analysis & Trends
Cellectis' Deferred Taxes history runs 4 years deep, the most recent figure standing at -$1.7 million for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Cellectis | 306.61 Mn | 120.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.70 Mn |
| Sep 30, 2025 | -18.92 Mn |
| Jun 30, 2025 | -8.90 Mn |
| Mar 31, 2025 | -3.36 Mn |
| Sep 30, 2024 | -1.98 Mn |
| Jun 30, 2024 | -3.92 Mn |
| Mar 31, 2024 | 12.67 Mn |
| Sep 30, 2023 | -121,000.00 |
| Jun 30, 2023 | -98,000.00 |
| Mar 31, 2023 | 278,000.00 |